SCHEMBL21895589

SCHEMBL21895589

C=CC[C@@H](CCCC)COc1nc(CC)c(CCC)c(N(CCC(C=C)C(=O)C=C)CC(C)CC#N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25020009 0.89 — —
SCHEMBL21912169 0.82 — —
SCHEMBL21895575 0.81 — —
SCHEMBL21846275 0.77 — —
SCHEMBL21912368 0.77 — —
SCHEMBL21912124 0.77 — —
SCHEMBL21895630 0.76 — —
SCHEMBL21895733 0.74 — —
SCHEMBL21846280 0.72 — —
SCHEMBL25021702 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055756-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
Send feedback